Harmony Biosciences Holdings, Inc.
HRMYNASDAQHealthcare● Active
$32.40
+$0.20(+0.62%)
Market Cap$1.9B
P/E Ratio—
52W High$40.87
52W Low$25.52
Harmony Biosciences Holdings, Inc.（HRMY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HRMY · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.87B | $0.71B | $0.58B | $0.44B | $0.31B |
| Cost of Revenue | $0.20B | $0.16B | $0.12B | $0.08B | $0.06B |
| Gross Profit | $0.67B | $0.56B | $0.46B | $0.35B | $0.25B |
| Gross Margin %(computed) | 77.16% | 78.06% | 79.17% | 80.93% | 81.82% |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.15B | $0.08B | $0.07B | $0.03B |
| G&A Expenses | $0.15B | $0.11B | $0.10B | $0.08B | $0.06B |
| Total Operating Expenses | $0.46B | $0.37B | $0.27B | $0.23B | $0.16B |
| Operating Income | $0.21B | $0.19B | $0.19B | $0.12B | $0.09B |
| Operating Margin %(computed) | 24.00% | 26.70% | 32.99% | 27.45% | 28.66% |
| Interest Income | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.02B | $0.02B | $0.02B | $0.02B |
| Income Before Tax | $0.22B | $0.19B | $0.17B | $0.10B | $0.04B |
| Income Tax Expense | $0.06B | $0.05B | $0.04B | ($0.08B) | $0.00B |
| Net Income | $0.16B | $0.15B | $0.13B | $0.18B | $0.03B |
| Net Margin %(computed) | 18.27% | 20.36% | 22.14% | 41.44% | 11.33% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.76 | $2.56 | $2.17 | $3.07 | $0.60 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| EBITDA | $0.26B | $0.23B | $0.22B | $0.15B | $0.08B |
| EBITDA Margin %(computed) | 29.37% | 32.66% | 38.06% | 33.54% | 26.34% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Harmony Biosciences Holdings, Inc.
关于Harmony Biosciences Holdings, Inc.（HRMY）损益表
Harmony Biosciences Holdings, Inc.（HRMY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，HRMY实现营收$0.87B，毛利润$0.67B（毛利率77.16%），净利润$0.16B（净利率18.27%）。
常见问题
HRMY · 4 问Harmony Biosciences Holdings, Inc.（HRMY）2025财年营收为$0.87B，同比up21.5%。
HRMY revenueHRMY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08